Skip to main content

Vor Biopharma Inc.

VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001817229

In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Vor Biopharma Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of VOR: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders4635−11
Shares60.1M57.1M−3.06M (−5.1%)
Value$43.2M$91.9M+$48.7M (+112.9%)

New holders (8)

Institutions that held Vor Biopharma Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to VOR in Q2 2025
InstitutionSharesValue% of portfolio
HRT Financial LP474,575$768.0K0.00%
Scientech Research LLC403,859$654.3K0.16%
Virtu Financial LLC275,912$447.0K0.02%
Two Sigma Securities, LLC94,394$152.9K0.02%
Citigroup Inc87,485$141.7K0.00%
XTX Topco Ltd40,943$66.3K0.00%
NBC Securities, Inc.1,000$1.00K0.00%
Allworth Financial LP60$980.00%

Sold out (19)

Institutions that held Vor Biopharma Inc. at the end of Q1 2025 and filed for Q2 2025 without it.